Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tauzin Will Tackle Device Reforms Outside PDUFA; Eshoo Urges Hearings

This article was originally published in The Gray Sheet

Executive Summary

House Energy & Commerce Committee Chairman Billy Tauzin (R-La.) will work with medical device reform bill sponsors to move HR 3580 independently of Prescription Drug User Fee Act reauthorization

You may also be interested in...



IVD National Fee Schedule, MDUFMA Oversight Among AdvaMed 2003 Goals

Securing adequate Medicare payment for in vitro diagnostics is one of several legislative priorities for AdvaMed in 2003

IVD National Fee Schedule, MDUFMA Oversight Among AdvaMed 2003 Goals

Securing adequate Medicare payment for in vitro diagnostics is one of several legislative priorities for AdvaMed in 2003

Device Reform Bill’s Future Murky; PDUFA Inclusion Unlikely, Members Say

A letter to key congressional leaders from several medical device trade associations appears to be a last-ditch effort by the industry to urge the inclusion of medical device reform provisions in legislation reauthorizing the Prescription Drug User Fee Act

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016235

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel